J9314 Injection pemetrexed (teva) 10mg
Also known as: pemetrexed Teva, pemetrexed generic
Injection of pemetrexed from Teva manufacturer, 10 milligram. Generic multi-targeted antifolate for lung cancer and mesothelioma.
In Plain Language
lung cancer injection; mesothelioma treatment
Clinical Context
Teva manufactured pemetrexed for nonsquamous non-small cell lung cancer and malignant pleural mesothelioma therapy.
RVU Information
CPT J9314 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J9314?
CPT J9314 (Injection pemetrexed (teva) 10mg) is a J Codes (Drugs) code. Injection of pemetrexed from Teva manufacturer, 10 milligram. Generic multi-targeted antifolate for lung cancer and mesothelioma.
How is J9314 administered?
CPT J9314 is administered by a healthcare provider, typically via injection or infusion. Teva manufactured pemetrexed for nonsquamous non-small cell lung cancer and malignant pleural mesothelioma therapy. It is used by Oncology, Pulmonology, Surgery.
When is CPT J9314 used?
Teva manufactured pemetrexed for nonsquamous non-small cell lung cancer and malignant pleural mesothelioma therapy.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.